Ra Capital Management, L.P. Adicet Bio, Inc. Transaction History
Ra Capital Management, L.P.
- $4.82 Billion
- Q1 2025
A detailed history of Ra Capital Management, L.P. transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 7,541,000 shares of ACET stock, worth $4.6 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
7,541,000
Previous 7,541,000
-0.0%
Holding current value
$4.6 Million
Previous $7.24 Million
20.83%
% of portfolio
0.12%
Previous 0.12%
Shares
3 transactions
Others Institutions Holding ACET
# of Institutions
63Shares Held
57.5MCall Options Held
36.9KPut Options Held
16.5K-
Orbimed Advisors LLC San Diego, CA11.4MShares$6.98 Million0.27% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$5.02 Million0.41% of portfolio
-
Goldman Sachs Group Inc New York, NY3.82MShares$2.33 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$1.96 Million0.0% of portfolio
-
Carlyle Group Inc. Washington, DC2.95MShares$1.8 Million2.78% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $24.4M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...